- OVERALL COMPONENT This is an application for a 5 year competitive renewal for the Colorado Nutrition Obesity Research Center (NORC). The MISSION of the Colorado NORC is to advance the science of nutrition and obesity by facilitating interdisciplinary, collaborative, translational research and by fostering the development of the next generation of scientists in the Rocky Mountain region. We are now in our twenty-fifth year of operation, and the Colorado NORC now supports 118 Regular Members, 22 Affiliate Member trainees, and 38 other Affiliate Member faculty scientists and educators. Our regular members generate over $51 million annually in direct costs for nutrition/obesity research. We have secured an additional $20 million in institutional resources to support the NORC's research and educational objectives over the next 5 years. This investment builds upon a $40 million investment from the University of Colorado and its philanthropic donors over the past 10 years to construct and operate the Anschutz Health and Wellness Center and build programmatically in the science of nutrition, obesity, and wellness. Our research base pursues basic, preclinical, clinical, and community research projects, with a mindset for interdisciplinary collaboration. The CENTRAL THEME of the Colorado NORC is the prevention and treatment of obesity and its metabolic complications across the lifespan, through better nutrition, lifestyle modifications, and medical treatments. We specifically build and foster interdisciplinary research on nutrition and obesity in five areas: 1) Early Life Influences; 2) Women's Health and Sex Differences; 3) Exercise and Metabolism; 4) Regulation of Metabolism; and 5) Nutrition and Weight Management Interventions for Better Health. The Colorado NORC has strong leadership with Dr. Paul MacLean (Director) and Dr. Daniel Bessesen (Associate Director), who will coordinate the activities of an impactful enrichment program, a successful pilot program, and three highly productive research cores. They have established strong partnerships with campus leaders that bridge disciplines for collaborative research. They have guided the cores and programs to adapt to the changing needs of the NORC's research base. Finally, they have recruited an outstanding team of core/program leaders and internal/external advisors that will ensure the Colorado NORC accomplishes its mission. After 25 years of operation, the Colorado has never been as well-positioned to advance the science of nutrition and obesity on so many fronts and to foster the next generation of leaders in these fields.

Public Health Relevance

- OVERALL COMPONENT The Colorado NORC will advance the science of nutrition and obesity by facilitating interdisciplinary, collaborative, translational research and by fostering the development of the next generation of scientists in the Rocky Mountain region. The Colorado NORC will accomplish this mission by support a research base of 118 funded scientists and their trainees with a pilot program, an enrichment program, and three biomedical research cores.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Evans, Mary
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Schools of Medicine
United States
Zip Code
Lee, J Scott; Wang, Ruth X; Alexeev, Erica E et al. (2018) Hypoxanthine is a checkpoint stress metabolite in colonic epithelial energy modulation and barrier function. J Biol Chem 293:6039-6051
Choi, Soo Youn; Lim, Sun Woo; Salimi, Shabnam et al. (2018) Tonicity-Responsive Enhancer-Binding Protein Mediates Hyperglycemia-Induced Inflammation and Vascular and Renal Injury. J Am Soc Nephrol 29:492-504
Bjornstad, Petter; Pyle, Laura; Cherney, David Z I et al. (2018) Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study. Nephrol Dial Transplant 33:1189-1196
Iwamoto, Sean; Saxon, David; Tsai, Adam et al. (2018) Effects of Education and Experience on Primary Care Providers' Perspectives of Obesity Treatments during a Pragmatic Trial. Obesity (Silver Spring) 26:1532-1538
Wang, Xiaoxin X; Wang, Dong; Luo, Yuhuan et al. (2018) FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J Am Soc Nephrol 29:118-137
Scalzo, Rebecca L; Bauer, Timothy A; Harrall, Kylie et al. (2018) Acute vitamin C improves cardiac function, not exercise capacity, in adults with type 2 diabetes. Diabetol Metab Syndr 10:7
Montasser, May E; O'Hare, Elizabeth A; Wang, Xiaochun et al. (2018) An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels. Circulation 138:1343-1355
Rozance, Paul J; Zastoupil, Laura; Wesolowski, Stephanie R et al. (2018) Skeletal muscle protein accretion rates and hindlimb growth are reduced in late gestation intrauterine growth-restricted fetal sheep. J Physiol 596:67-82
Abbate, Lauren M; Jeffreys, Amy S; Coffman, Cynthia J et al. (2018) Demographic and Clinical Factors Associated With Nonsurgical Osteoarthritis Treatment Among Patients in Outpatient Clinics. Arthritis Care Res (Hoboken) 70:1141-1149
Cara-Fuentes, Gabriel; Lanaspa, Miguel A; Garcia, Gabriela E et al. (2018) Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease. Pediatr Nephrol 33:1101-1103

Showing the most recent 10 out of 756 publications